Gilead Sciences

GILD

GILD
Gilead Sciences Stock Quote
$66.72 $0.76 1.2%
BATS BZX Real Time Price as of September 20, 2019, 1:50 p.m. EDT View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

News & Analysis: Gilead Sciences

The Fool has written over 1400 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings











Interactive Chart